Ivalue Infosolut (IVALUE)

FairStock Score: 55/100 — STEADY

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 25.77% indicates strong capital efficiency
• Low debt/equity of 0.20 provides financial stability
• Profit growth of 11.69% despite falling sales shows margin discipline
• P/E of 13.15 and PEG of 1.12 point to reasonable valuation if earnings hold
• Piotroski F-Score of 6/9 suggests acceptable financial health

Concerns

• Sales growth negative at -13.04%, raising doubts about demand sustainability
• No dividend yield means zero cash return to shareholders
• Promoter holding of only 32.08% is moderate, not strongly aligned
• P/B of 2.89 offers little margin of safety above book value

AI Analysis

When I look at Ivalue Infosolut, I see a business that is neither simple nor cheap enough for my taste, but it has some interesting numbers. The market is valuing the whole enterprise at ₹1,229 crore, with a price of ₹267.10. At a P/E of 13.15, you are paying a reasonable multiple for reported earnings. The company has earned a return on capital employed of 25.77%, which is impressive, and it carries very little debt—only 0.20 times equity. That suggests management knows how to run the business without leverage. But I cannot ignore the sales figure: sales have declined by 13.04%. Yet profit has grown by 11.69%. That is a strange combination. It means the company is making more money on lower revenue, perhaps through better cost controls or a change in product mix. As an investor, I would want to understand whether that is sustainable or simply a one-time effect. The book value is ₹92.41, so the stock trades at 2.89 times book. That is not a bargain. There is no dividend, so your only return is the hope that earnings and the price move higher. With promoter holding at 32.08%, I worry about how well aligned interests are with minority shareholders. The Piotroski score of 6 out of 9 is middling—not a red flag, but not a ringing endorsement. If I am generous, a PEG ratio of 1.12 suggests the stock is fairly priced given current profit growth. But in my view, negative revenue growth makes those profits fragile. I would want to see sales turn positive before I invest. For now, this is a possible turnaround, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer